MRP ₹271
(Inclusive of all Taxes)
₹40.6 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
निर्माता/मार्केटर :
इप्का लैबोरेटरीज लिमिटेड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इस तारीख को या बाद में समाप्त हो रहा है :
Jan-27
Health Queries
Dr S Aneela
M. Pharm (Pharmacology)., PhD
Both CTD-T 12.5/80 Tablet (Telmisartan and Chlorthalidone) and Cilacar 10 Tablet (Cilnidipine) may sometimes cause constant tiredness (fatigue) due to lowered blood pressure or electrolyte imbalances. Fatigue may also occur from dehydration, anaemia, thyroid problems, or uncontrolled blood pressure. Please consult your doctor to review your medications, identify any underlying causes, and guide appropriate management.
Dr S Aneela
M. Pharm (Pharmacology)., PhD
Your current BP of 140/90 is slightly above the recommended target, so your medication may need adjustment. The appropriate combination depends on your BP readings, lifestyle factors, kidney function, and how well you tolerate your current medicine. Please consult your doctor to review your readings and determine whether CTD-O 12.5/40 Tablet or another combination would be more suitable for you.
Dr S Aneela
M. Pharm (Pharmacology)., PhD
Yes, CTD-T 12.5/80 Tablet, which contains Telmisartan and Chlorthalidone, can be an appropriate option for managing hypertension. Telmisartan helps relax and widen blood vessels, while Chlorthalidone reduces fluid retention. Your doctor will assess your blood pressure, kidney function, and electrolyte levels to confirm whether this combination is suitable for you.
Dr S Aneela
M. Pharm (Pharmacology)., PhD
Severe hypertension can be triggered by several factors, including stress, obesity, a high-sodium diet, missed medications, or underlying conditions such as kidney disease. It is crucial to monitor your blood pressure regularly and note any patterns or triggers. Consult your doctor to identify the cause and adjust your treatment to prevent future episodes. Making lifestyle changes, such as improving your diet and incorporating regular exercise, can also help control your blood pressure.
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with CTD-O 12.5/40 Tablet:
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking CTD-O 12.5/40 Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking CTD-O 12.5/40 Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
Critical
How does the drug interact with CTD-O 12.5/40 Tablet:
Co-administration of CTD-O 12.5/40 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-O 12.5/40 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of CTD-O 12.5/40 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-O 12.5/40 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
How does the drug interact with CTD-O 12.5/40 Tablet:
Coadministration of CTD-O 12.5/40 Tablet with perindopril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with perindopril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Coadministration of CTD-O 12.5/40 Tablet with perindopril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with perindopril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Olmesartan medoxomilpotassium phosphate
Severe
How does the drug interact with CTD-O 12.5/40 Tablet:
Using potassium phosphate together with olmesartan may significantly increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet and potassium phosphate together can cause an interaction, it can be taken if a doctor has suggested it. However if you experience symptoms such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, consult a doctor. It is crucial that you continue to consume enough fluids while taking these medications. Do not discontinue any medications without consulting a doctor.
Using potassium phosphate together with olmesartan may significantly increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet and potassium phosphate together can cause an interaction, it can be taken if a doctor has suggested it. However if you experience symptoms such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, consult a doctor. It is crucial that you continue to consume enough fluids while taking these medications. Do not discontinue any medications without consulting a doctor.
Olmesartan medoxomilTriamterene
Severe
How does the drug interact with CTD-O 12.5/40 Tablet:
Taking CTD-O 12.5/40 Tablet with triamterene may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with triamterene may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking CTD-O 12.5/40 Tablet with triamterene may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with triamterene may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with CTD-O 12.5/40 Tablet:
Taking CTD-O 12.5/40 Tablet with trimethoprim may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with trimethoprim may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking CTD-O 12.5/40 Tablet with trimethoprim may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with trimethoprim may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with CTD-O 12.5/40 Tablet:
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with CTD-O 12.5/40 Tablet:
CTD-O 12.5/40 Tablet when combined with benazepril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with benazepril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
CTD-O 12.5/40 Tablet when combined with benazepril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet with benazepril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with CTD-O 12.5/40 Tablet:
Coadministration of CTD-O 12.5/40 Tablet with enalapril can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with enalapril may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of CTD-O 12.5/40 Tablet with enalapril can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with enalapril may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Olmesartan medoxomilPotassium citrate
Severe
How does the drug interact with CTD-O 12.5/40 Tablet:
Coadministration of CTD-O 12.5/40 Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Coadministration of CTD-O 12.5/40 Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking CTD-O 12.5/40 Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
CHLORTHALIDONE-12.5MG+OLMESARTAN MEDOXOMIL-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-12.5MG+OLMESARTAN MEDOXOMIL-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
When CTD-O 12.5/40 Tablet is taken along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid taking potassium-containing salt substitutes or over-the-counter potassium supplements with CTD-O 12.5/40 Tablet as this can lead to high potassium levels in the blood. However, consult a doctor if you experience weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
When CTD-O 12.5/40 Tablet is taken along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid taking potassium-containing salt substitutes or over-the-counter potassium supplements with CTD-O 12.5/40 Tablet as this can lead to high potassium levels in the blood. However, consult a doctor if you experience weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
All Substitutes & Brand Comparisons
RX
Olmenorm-CTD/40 Tablet 10's
Remedy Life Sciences Pvt Ltd
₹103
(₹9.27 per unit)
61% CHEAPERRX
Olmetime-CT 40 Tablet 10's
Mankind Pharma Pvt Ltd
₹166
(₹14.94 per unit)
38% CHEAPERRX
Olmetop 40 CT Tablet 15's
Elbrit Life Sciences Pvt Ltd
₹267
(₹16.02 per unit)
34% CHEAPER
शराब
असुरक्षित
अप्रिय दुष्प्रभावों से बचने के लिए आपको सीटीडी-ओ 12.5/40 टैबलेट 10's के साथ शराब का सेवन न करने की सलाह दी जाती है।
गर्भावस्था
असुरक्षित
सीटीडी-ओ 12.5/40 टैबलेट 10's को तब तक नहीं लेना चाहिए जब तक कि डॉक्टर द्वारा निर्धारित न किया जाए। सीटीडी-ओ 12.5/40 टैबलेट 10's एक श्रेणी C/D गर्भावस्था वाली दवा है जिसे गर्भवती महिलाओं के लिए असुरक्षित माना जाता है। सीटीडी-ओ 12.5/40 टैबलेट 10's का बच्चे (गर्भस्थ शिशु) पर कुछ हानिकारक प्रभाव पड़ सकते हैं, आपका डॉक्टर आपको यह दवा लिखने से पहले इसके फायदे और किसी भी संभावित जोखिम का आकलन करेगा। कृपया अपने डॉक्टर से सलाह लें।
स्तनपान
असुरक्षित
सीटीडी-ओ 12.5/40 टैबलेट 10's स्तनपान कराने वाली माताओं के लिए अनुशंसित नहीं है। यह दूध में कम मात्रा में उत्सर्जित होता है और धीरे-धीरे साफ होता है। यह शिशु, विशेष रूप से नवजात शिशुओं या समय से पहले जन्म लेने वाले शिशुओं में जमा हो सकता है। सीटीडी-ओ 12.5/40 टैबलेट 10's के प्रभाव के कारण दुग्ध उत्पादन भी दबा हुआ हो सकता है।
ड्राइविंग
असुरक्षित
सीटीडी-ओ 12.5/40 टैबलेट 10's लेने के बाद गाड़ी चलाने की सलाह नहीं दी जाती है क्योंकि इससे कभी-कभी उनींदापन या थकान हो सकती है।
जिगर
सावधानी
सीटीडी-ओ 12.5/40 टैबलेट 10's सावधानी के साथ लेना चाहिए, खासकर यदि आपको लीवर की बीमारियों/स्थितियों का इतिहास रहा है। आपके डॉक्टर द्वारा खुराक को समायोजित करने की आवश्यकता हो सकती है।
गुर्दा
सावधानी
सीटीडी-ओ 12.5/40 टैबलेट 10's सावधानी के साथ लेना चाहिए, खासकर यदि आपको गुर्दे की बीमारियों/स्थितियों का इतिहास रहा है। आपके डॉक्टर द्वारा खुराक को समायोजित करने की आवश्यकता हो सकती है।
बच्चे
असुरक्षित
1 वर्ष से कम उम्र के बच्चों में सीटीडी-ओ 12.5/40 टैबलेट 10's के उपयोग की अनुशंसा नहीं की जाती है क्योंकि इन आयु समूहों में सीटीडी-ओ 12.5/40 टैबलेट 10's की सुरक्षा और प्रभावकारिता अभी तक स्थापित नहीं हुई है।
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
